Development of an App for Symptom Management in Women With Breast Cancer Receiving Maintenance Aromatase Inhibitors: Protocol for a Mixed Methods Feasibility Study.

Lund-Jacobsen, Trine; Schwarz, Peter; Martino, Gabriella; Pappot, Helle; Piil, Karin

Lund-Jacobsen, Trine; Schwarz, Peter; Martino, Gabriella; Pappot, Helle; Piil, Karin.

Afiliação

Lund-Jacobsen T; Department of Endocrinology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Schwarz P; Department of Endocrinology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Martino G; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Pappot H; Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Piil K; Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

JMIR Res Protoc ; 13: e49549, 2024 Feb 15.

Article em En | MEDLINE | ID: mdl-38358787

Palavras-chave

QoL; acceptability; aromatase inhibitors; breast cancer; cancer; chemotherapy; disease; feasibility; inhibitor; mHealth; management; postmenopausal; psychosocial; quality of life; radiation therapy; symptom; symptom management; tool; treatment; usability; user-friendliness

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google